The occurrence of postoperative pulmonary homograft stenosis in adult patients undergoing the Ross procedure

Journal of Heart Valve Disease

Volumn 15, Issue 1, 2006, Pages 108-114

  Ryan, William H ^a   Herbert, Morley A ^c   Dewey, Todd M ^b,c   Agarwal, Shivum ^b   Ryan, Anne L ^b   Prince, Syma L ^b   Mack, Michael J ^b,c  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^b Cardiopulmonary Research Science and Technology Institute   (United States)

^c MEDICAL CITY DALLAS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD GROUP TYPING; BLOOD VESSEL DIAMETER; BODY SURFACE; CHI SQUARE TEST; CONTROLLED STUDY; CRYOPRESERVATION; DATA ANALYSIS; DONOR SELECTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GRAFT PRESERVATION; HEART VALVE REPLACEMENT; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; SEX DIFFERENCE; STUDENT T TEST; SURGICAL TECHNIQUE; TRANSLUMINAL VALVULOPLASTY;

ADOLESCENT; ADULT; AGED; AORTIC VALVE; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PULMONARY VALVE; PULMONARY VALVE STENOSIS; REOPERATION; SEX FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 31844434440     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet 1967;4: 956-958
2. Oswalt JD, Dewan SJ, Mueller MC, Nelson S. Highlights of a ten-year experience with the Ross procedure. Ann Thorac Surg 2001;71:S332-S335
3. Stelzer P, Weinrauch S, Tranbaugh RF. Ten years of experience with the modified Ross procedure. J Thorac Cardiovasc Surg 1998;115:1091-1100
4. Dagenais F, Cartier P, Voisine P, et al. Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? J Thorac Cardiovasc Surg 2005;129:1041-1049
5. Elkins RC, Knott-Craig CJ, Ward KE, McCue C, Lane MM. Pulmonary autograft in children: Realized growth potential. Ann Thorac Surg 1994;57:1387-1393
6. David TE, Omran A, Webb G, Rakowski H, Armstrong S, Sun Z. Geometric mismatch of the aortic and pulmonary roots causes aortic insufficiency after the Ross procedure. J Thorac Cardiovasc Surg 1996;112:1231-1237
7. Elkins RC, Lane MM, McCue C. Pulmonary autograft reoperation: Incidence and management. Ann Thorac Surg 1996;62:450-455
8. Raanani E, Yau TM, David TE, Dellgren G, Sonnenberg BD, Omran A. Risk factors for late pulmonary homograft stenosis after the Ross procedure. Ann Thorac Surg 2000;70:1953-1957
9. Lamberti JJ, Mainwaring RD, Billman GF, et al. The cryopreserved homograft valve in the pulmonary position: Mid-term results and technical considerations. J Card Surg 1991;6:S627-S632
10. Carr-White GS, Kilner PJ, Hon JK, et al. Incidence, location, pathology, and significance of pulmonary homograft stenosis after the Ross operation. Circulation 2001;104:SI16-SI20
11. Feier H, Collart F, Ghez O, et al. Risk factors, dynamics, and cut-off values for homograft stenosis after the Ross procedure. Ann Thorac Surg 2005;79:1669-1675
12. Hoekstra F, Witvliet M, Knoop C, et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts. J Heart Lung Transplant 1997;16:570-572
13. Bando K, Danielson GK, Schaff HV, Mair DD, Julsrud PR, Puga FJ. Outcome of pulmonary and aortic homografts for right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 1995;109:509-517
14. Niwaya K, Knott-Craig CJ, Lane MM, Chandrasekaren K, Overholt ED, Elkins RC. Cryopreserved homograft valves in the pulmonary position: Risk analysis for intermediate-term failure. J Thorac Cardiovasc Surg 1999;117:141-146
15. Capps SB, Elkin RC, Fronk DM. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg 2000;119:975-982
16. Moidl R, Simon P, Kupilik N, et al. Increased pulmonary flow velocities in oversized homografts in patients after the Ross procedure. Eur J Cardiothorac Surg 1997;12:569-572
17. Ward KE, Elkins RC, Overholt ED, et al. Evaluation of cryopreserved homografts in the right ventricular outflow tract after the Ross procedure: Intermediate-term follow up. J Heart Valve Dis 1997;6:130-133
18. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102:III130-III135
19. Forbess JM, Shah AS, St. Louis JD, Jaggers JJ, Ungerleider RM. Cryopreserved homografts in the pulmonary position: Determinants of durability. Ann Thorac Surg 2001;71:54-59
20. Capps SB, Elkins RC, Fronk DM. Body surface area as a predictor of aortic and pulmonary valve diameter. J Thorac Cardiovasc Surg 2000;119:975-982
21. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 1995;60:S127-S130
22. Hoekstra FM, Witvliet M, Knoop CY, et al. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg 1998;66:2022-2026
23. Baskett RJ, Nanton MA, Warren AE, Ross DB. Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: Implications for therapeutic interventions. J Thorac Cardiovasc Surg 2003;126:232-239
24. Christenson JT, Vala D, Sierra J, Beghetti M, Kalangos A. Blood group incompatibility and accelerated homograft fibrocalcifications. J Thorac Cardiovasc Surg 2004;127:242-250
25. Kadner A, Chen RH, Mitchell RN, Adams DH. Hemograft crossmatching is unnecessary due to the absence of blood group antigens. Ann Thorac Surg 2001;71:S349-S352
26. Marshall MB, Kohman LJ. Gender and lung transplantation: Size matters, does sex? J Thorac Cardiovasc Surg 2004;128:352-353
27. Prendergast TW, Furukawa S, Beyer AJ, III, Browne BJ, Eisen HJ, Jeevanandam V. The role of gender in heart transplantation. Ann Thorac Surg 1998;65:88-94
28. Mehra MR, Stapleton DD, Ventura HO, et al. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study. Circulation 1994;90:II78-II82
29. Kahn D, Gavaler JS, Makowka L, van Thiel DH. Gender of donor influences outcome after orthotopic liver transplantation in adults. Dig Dis Sci 1993;38:1485-1488
30. Marino IR, Doyle HR, Aldrighetti L, et al. Effect of donor age and sex on the outcome of liver transplantation. Hepatology 1995;22:1754-1762
31. Brooks BK, Levy MF, Jennings LW, et al. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 1996;62:1784-1787
32. Gafter U, Ben-Bassat M, Levi J. Castration inhibits glomerular hypertrophy and proteinuria in uninephrectomized male rats. Eur J Clin Invest 1990;20:360-365
33. Neugarten J, Silbiger SR. The impact of gender on renal transplantation. Transplantation 1994;15:1145-1152
34. Vereerstraeten P, Wissing M, De Pauw L, Abramowicz D, Kinnaert P. Male recipients of kidneys from female donors are at increased risk of graft loss from both rejection and technical failure. Clin Transplant 1999;13:181-186